drugset / Trial / NCT02056743

Clinical Trials on Evaluate the Red Ginseng and Fermented-Red Ginseng Affect to Drug Metabolizing Enzyme and Transporter in Healthy Volunteers

NCT02056743

Phase 1 Completed 30 enrolled Chonbuk National University Hospital
RandomizedParallel-groupOpen-label

Summary

The purpose of this study is to evaluate the possibility of drug interactions before and after taking red ginseng or fermented-red ginseng by estimating metabolic rate of indicator drugs for cytochrome P450 and P-glycoprotein.

Timeline

Start
2013-09
Primary completion
2013-10
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Caffeine Small molecule 200 mg
Subject Dextromethorphan Unknown 30 mg
Subject Fexofenadine Unknown 30 mg
Subject Losartan Other / unclassified 50 mg
Subject Midazolam Small molecule 7.5 mg
Subject Omeprazole Other / unclassified 20 mg

Indications

No indication recorded.